CIMSS
CIMSS is a U.S. digital health company that builds a medication adherence platform for physicians, combining sensor-equipped devices, reminder systems, and mobile applications to help clinicians monitor and improve patient compliance with prescribed drug regimens.
- Company typePrivate
- Founded2011
- HeadquartersDes Plaines, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What CIMSS does
CIMSS, formally Comprehensive Integrated Management Systems and Solutions, is a privately held U.S. digital health company headquartered in Des Plaines, Illinois, founded in 2011 and operating with 11–50 employees. The company builds a medication adherence technology platform aimed at physicians and healthcare providers, designed to help clinicians monitor and improve patient compliance with prescribed drug regimens. The product combines connected hardware — sensor-equipped devices that detect medication events — with reminder systems and mobile applications that prompt patients and surface adherence data to their physicians. The core value proposition targets the well-documented problem of medication non-adherence, framing better compliance as a mechanism to improve patient outcomes while reducing downstream healthcare costs.
In December 2022, CIMSS acquired RxCompli, a medication adherence solution that provides sensor-based devices and reminder-driven applications for patients. The acquisition was integrated into CIMSS's platform and represents the company's most significant documented corporate action; no other funding rounds, partnerships, leadership changes, geographic expansions, or product launches are recorded in the available sources. CIMSS operates in a single declared customer vertical — physicians and healthcare providers — and its segmentation approach is vertical rather than horizontal. No pricing model, customer pricing tiers, distribution channels, or marketing channels are publicly disclosed, and there are no recorded certifications, patents, regulatory actions, or named enterprise customers.
The publicly observable business model is therefore incomplete: CIMSS appears to monetize the platform through physician or provider adoption, but the absence of disclosed pricing, contract structures, revenue figures, or headcount trajectory limits any deeper revenue-mix inference. Limited third-party coverage and the company website returning only a loading state further constrain visibility into operations, leadership, and growth metrics beyond the single acquisition event.
CIMSS firmographics
Firmographics- Name
- CIMSS
- Website
- https://cimss.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- CIMSS is a U.S. digital health company that builds a medication adherence platform for physicians, combining sensor-equipped devices, reminder systems, and mobile applications to help clinicians monitor and improve patient compliance with prescribed drug regimens.
- Ownership category
- akta.pro rank
CIMSS industry classification
Industry- Product category
- Medication Adherence Technology
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)
Keywords
Where CIMSS is headquartered
LocationHeadquarters
- HQ city
- Des Plaines
- HQ country
- United States
- HQ region
- North America
Markets served
CIMSS business model
Business model- GTM type
- B2B
- Offering type
- Software
CIMSS product offering
Product offeringCore offering
CIMSS (Comprehensive Integrated Management Systems and Solutions) provides a medication adherence technology platform designed for physicians and healthcare providers. The platform integrates sensors, reminder-based devices, and mobile applications that monitor and improve patient medication compliance, aiming to enhance patient outcomes and reduce healthcare costs associated with medication non-adherence.
Product overview
CIMSS offers a medication adherence technology platform for physicians. The platform integrates the acquired RxCompli product line, which provides sensors and reminder-based devices and apps designed to help ensure patients take their medications correctly, ultimately aiming to improve patient outcomes and reduce healthcare costs.
Differentiator
Problem solved
Functional benefit
Products and services
- Medication Adherence Technology Platform
- RxCompli
Quantifiable outcome
- Improve patient outcomes through better medication adherence
- +1 more outcomes
Companies that use CIMSS
Customer profileSegments1 record
CIMSS technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CIMSS partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- RxComplicoreCIMSS acquired RxCompli to enhance its medication adherence technology platform. The acquisition enables CIMSS to offer devices and apps that ensure patients take medications correctly, using sensors and reminders. This strategic acquisition expands CIMSS's capabilities in connected health and patient monitoring solutions.
Recent moves2 records
Expansion highlights3 records
CIMSS competitors and assessment
Company assessmentDirect peers
- Hero Health: Hero offers a connected medication dispenser and reminder platform for patients and caregivers. It overlaps with CIMSS's RxCompli line in the smart medication management category for chronic patients.
- Pillsy: Pillsy developed a smart pill bottle with sensors and reminders and a companion app. It is a direct early-stage peer to CIMSS in consumer and provider-facing medication adherence technology.
- MedMinder: MedMinder provides smart pill dispensers with reminder alerts and remote monitoring, primarily for seniors and chronic care patients. It competes directly with CIMSS in connected medication adherence hardware.
- AdhereTech: AdhereTech builds smart pill bottles with sensors and reminders to improve medication adherence. It is a direct competitor to CIMSS, addressing the same physician and patient use case with connected device technology.
- Medisafe: Medisafe is a digital medication adherence platform with mobile apps, reminders, and provider dashboards. It is a direct software-focused peer to CIMSS's physician-facing adherence platform.
Emerging players
- Caregility: Caregility provides virtual care and patient monitoring platforms used by hospitals and clinicians. Its connected patient monitoring capabilities partially overlap with CIMSS's adherence monitoring focus.
- TrialCard: TrialCard (now Medicus) offers patient adherence and engagement solutions for pharma and providers, including affordability and adherence programs. It overlaps with CIMSS in adherence and patient engagement.
- Propeller Health: Propeller Health (a ResMed company) offers sensor-based medication adherence for respiratory conditions like asthma and COPD. It overlaps with CIMSS in connected adherence devices for chronic disease management.
Broad incumbents
- Omnicell: Omnicell is a large medication management and adherence solutions provider serving hospitals, pharmacies, and patients. It is a broad incumbent whose adherence offerings overlap with CIMSS's physician-focused platform.
- Philips (Medication Adherence / Care Solutions): Philips offers connected health and medication adherence solutions as part of its broader connected care portfolio. It is a broad incumbent with overlapping chronic disease and adherence monitoring capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
CIMSS social profiles
Digital presenceCIMSS financial estimates
Financial estimateRevenue estimate
Valuation estimate
CIMSS leadership team
Management profileNumber of profiles
CIMSS subsidiaries and ownership
Company hierarchySubsidiaries1 record
CIMSS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CIMSS M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CIMSS
What does CIMSS do?
CIMSS (Comprehensive Integrated Management Systems and Solutions) provides a medication adherence technology platform designed for physicians and healthcare providers. The platform integrates sensors, reminder-based devices, and mobile applications that monitor and improve patient medication compliance, aiming to enhance patient outcomes and reduce healthcare costs associated with medication non-adherence.
Is CIMSS a public or private company?
CIMSS is a private company. It is classified as unknown and is currently operating.
When was CIMSS founded?
CIMSS was founded in 2011. It employs 51 to 100 people.
Where is CIMSS based?
CIMSS is headquartered in Des Plaines, United States, in the North America region.
Who are CIMSS's main competitors?
Direct peers on record are Hero Health, Pillsy, MedMinder, AdhereTech and Medisafe. Emerging players are Caregility, TrialCard and Propeller Health. Broad incumbents are Omnicell and Philips (Medication Adherence / Care Solutions).
Does CIMSS have an API?
No public API is recorded for CIMSS.
What industry is CIMSS in?
CIMSS's product category is Medication Adherence Technology. Its primary akta.pro industry code is HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 54151 and its SIC code is 7373.